CY1108340T1 - Συνδυασμος του edg5 πολυμορφισμου v286a με σακχαρωδη διαβητη τυπου ii και φλeβικη θρομβωση / πνευμονικη εμβολη και η χρηση αυτου - Google Patents

Συνδυασμος του edg5 πολυμορφισμου v286a με σακχαρωδη διαβητη τυπου ii και φλeβικη θρομβωση / πνευμονικη εμβολη και η χρηση αυτου

Info

Publication number
CY1108340T1
CY1108340T1 CY20081100993T CY081100993T CY1108340T1 CY 1108340 T1 CY1108340 T1 CY 1108340T1 CY 20081100993 T CY20081100993 T CY 20081100993T CY 081100993 T CY081100993 T CY 081100993T CY 1108340 T1 CY1108340 T1 CY 1108340T1
Authority
CY
Cyprus
Prior art keywords
type
diabetes mellitus
edg5
pulmonary embolism
venous thrombosis
Prior art date
Application number
CY20081100993T
Other languages
English (en)
Inventor
Detlef Kozian
Evi Kostenis
Karl-Ernst Siegler
Martina Jacobs
Jean-Francois Deleuze
Sylvain Ricard
Sandrine Mace
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of CY1108340T1 publication Critical patent/CY1108340T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα εφεύρεση αφορά μια μέθοδο προσδιορισμού μιας αύξησης σε κίνδυνο για τον Σακχαρώδη διαβήτη τύπου ΙΙ ή/ και τη φλεβική θρόμβωση / πνευμονική εμβολή, όπου η παρουσία ανταλλαγής αμινοξέων στη θέση 286 από Βαλίνη (Val) σε Αλανίνη (Ala) στην πρωτεΐνη EDG5 ορίζεται σε έναν αισθητήρα.
CY20081100993T 2002-04-09 2008-09-16 Συνδυασμος του edg5 πολυμορφισμου v286a με σακχαρωδη διαβητη τυπου ii και φλeβικη θρομβωση / πνευμονικη εμβολη και η χρηση αυτου CY1108340T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02007879 2002-04-09
EP03729923A EP1527197B1 (en) 2002-04-09 2003-04-07 Association of edg5 polymorphism v286a with type ii diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof

Publications (1)

Publication Number Publication Date
CY1108340T1 true CY1108340T1 (el) 2014-02-12

Family

ID=28685845

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100993T CY1108340T1 (el) 2002-04-09 2008-09-16 Συνδυασμος του edg5 πολυμορφισμου v286a με σακχαρωδη διαβητη τυπου ii και φλeβικη θρομβωση / πνευμονικη εμβολη και η χρηση αυτου

Country Status (12)

Country Link
EP (1) EP1527197B1 (el)
JP (2) JP4284194B2 (el)
AT (1) ATE398684T1 (el)
AU (1) AU2003240449A1 (el)
CA (1) CA2481300A1 (el)
CY (1) CY1108340T1 (el)
DE (1) DE60321684D1 (el)
DK (1) DK1527197T3 (el)
ES (1) ES2307938T3 (el)
PT (1) PT1527197E (el)
SI (1) SI1527197T1 (el)
WO (1) WO2003085130A1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579516B1 (en) 1995-06-13 2003-06-17 Zahra Mansouri Methods of delivering materials into the skin, and compositions used therein
JP5904501B2 (ja) * 2010-09-02 2016-04-13 国立研究開発法人理化学研究所 ２型糖尿病の検出方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057126A (en) * 1997-12-24 2000-05-02 Allelix Biopharmaceuticals, Inc. Mammalian EDG-5 receptor homologs
EP1071708A4 (en) * 1998-04-23 2005-01-19 Smithkline Beecham Corp GENE OF THE EDG FAMILY, HUMAN H218

Also Published As

Publication number Publication date
JP2005522199A (ja) 2005-07-28
ES2307938T3 (es) 2008-12-01
SI1527197T1 (sl) 2008-10-31
CA2481300A1 (en) 2003-10-16
WO2003085130A1 (en) 2003-10-16
PT1527197E (pt) 2008-09-22
AU2003240449A1 (en) 2003-10-20
DK1527197T3 (da) 2008-10-20
EP1527197B1 (en) 2008-06-18
DE60321684D1 (de) 2008-07-31
JP4284194B2 (ja) 2009-06-24
ATE398684T1 (de) 2008-07-15
EP1527197A1 (en) 2005-05-04
JP4956565B2 (ja) 2012-06-20
JP2009171971A (ja) 2009-08-06

Similar Documents

Publication Publication Date Title
NO2017027I2 (no) efmoroctocog alfa eller et biotilsvarende legemiddel ihht Artikkel 10(4) av Directive 2001/83/EC, som beskyttet av basispatentet.
DK1092155T3 (da) Fremgangsmåde til tidlig diagnose af carcinomer
DK2230299T3 (da) Hidtil ukendt cytokin ZCYTOR17-ligand
DK1571970T3 (da) Diagnose og monitorering af sygdomme
CY1106876T1 (el) Συσκευασια και μεθοδος ανιχνευσεως της πρωτεϊνης esm-1
AU2003280753A1 (en) Kit for assaying human low-molecular weight cd14 and antibody
ATE322503T1 (de) Gefrierschutzprotein
DE60335726D1 (de) Chromoprotein und fluoroproteine
BR0310003A (pt) compostos peptìdeos e seu uso como substratos de protease
CY1108340T1 (el) Συνδυασμος του edg5 πολυμορφισμου v286a με σακχαρωδη διαβητη τυπου ii και φλeβικη θρομβωση / πνευμονικη εμβολη και η χρηση αυτου
DK1276763T3 (da) Anti-fryseproteiner, deres fremstilling og anvendelse
DK1400589T3 (da) Fremgangsmåde til påvisning af prokaryotisk DNA
NO20053990L (no) Assay for proteinisoformer
EP2071338A3 (en) Human diabetes-mediating proteins
ATE371192T1 (de) Diagnose von autismus
Brock et al. Characterization of monoferric fragments obtained by tryptic cleavage of bovine transferrin
NO20081503L (no) T-celle adhesjonsmolekyl, og antistoff dertil
ATE361320T1 (de) Monoklonaler antikörper gegen protein c inhibitor
NO20082864L (no) Nytt polypeptid med esteraseaktivitet og rekombinant esterase samt anvendelse derav
NO20061215L (no) Fremgangsmate for identifisering av IRS-proteinkinase-inbibitorer eller -agonister
Flores et al. Hydrolysis of alanine oligopeptides by porcine muscle alanyl aminopeptidase
SE0202608D0 (sv) New sequences
ATE397753T1 (de) Screening-verfahren für eine prophylaktische und therapeutische substanz für eine nierenerkrankung
DE60040010D1 (de) Ein Verfahren zum Auffinden vom Prostatakrebs
WO2002099045A3 (en) Peptide beta-strand mimics based on 1,2-dihydro-3(6h)-pyridinone